Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anti-D-dimer IgG antibody
- Development stage
- Preclinical
- Lead developer
- GETBO
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Anti-D-dimer IgG antibody is a murine, humanized monoclonal antibody conjugate developed for the in vivo real-time molecular imaging of thrombosis. Conjugated to the fluorescent reporter CF555, the antibody specifically targets D-dimer-rich regions within thrombi, allowing for the detection of active thrombotic sites and fibrin degradation products. This molecular probe is being developed to address the limitations of conventional venous thromboembolism (VTE) diagnostics, such as computed tomography pulmonary angiography (CTPA) and ultrasonography, by providing spatial specificity and biological activity information of the clot.
- Other names
- anti-D-dimer antibody conjugatefluorescently labelled anti-D-dimer antibodymurine monoclonal anti-D-dimer antibody conjugate
02
Targets
D-dimer
Beyond the preview
Go deeper on anti-D-dimer IgG antibody.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anti-D-dimer IgG antibody.